Sarcoma  >>  inhaled lipid cisplatin (ILC)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
inhaled lipid cisplatin (ILC) / Eleison Pharma
NCT01650090: Phase 2 Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma

Completed
2
28
US
Inhaled Lipid Cisplatin (ILC), Cisplatin, Lipid cisplatin complex
Eleison Pharmaceuticals LLC.
Pulmonary Relapse of Osteosarcoma
11/18
11/18

Download Options